1. Home
  2. LMFA vs MBIO Comparison

LMFA vs MBIO Comparison

Compare LMFA & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LM Funding America Inc.

LMFA

LM Funding America Inc.

HOLD

Current Price

$0.29

Market Cap

5.6M

Sector

Finance

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.73

Market Cap

5.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMFA
MBIO
Founded
2008
2015
Country
United States
United States
Employees
19
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
5.8M
IPO Year
2015
2023

Fundamental Metrics

Financial Performance
Metric
LMFA
MBIO
Price
$0.29
$0.73
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
356.8K
27.1K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
34.66
98.99
EPS
N/A
N/A
Revenue
$8,844,733.00
N/A
Revenue This Year
$4.38
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.53
52 Week High
$5.14
$7.00

Technical Indicators

Market Signals
Indicator
LMFA
MBIO
Relative Strength Index (RSI) 47.07 43.98
Support Level $0.18 $0.71
Resistance Level $0.44 $1.00
Average True Range (ATR) 0.03 0.05
MACD 0.01 0.01
Stochastic Oscillator 78.02 67.98

Price Performance

Historical Comparison
LMFA
MBIO

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: